<VariationArchive RecordType="classified" VariationID="14085" VariationName="NM_002473.6(MYH9):c.3195_3215dup (p.Gln1068_Leu1074dup)" VariationType="Duplication" Accession="VCV000014085" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-08-06" DateCreated="2015-10-11" MostRecentSubmission="2015-10-11">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="29124" VariationID="14085">
      <GeneList>
        <Gene Symbol="MYH9" FullName="myosin heavy chain 9" GeneID="4627" HGNC_ID="HGNC:7579" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>22q12.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="22" Accession="NC_000022.11" start="36281280" stop="36387967" display_start="36281280" display_stop="36387967" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="22" Accession="NC_000022.10" start="36677322" stop="36784062" display_start="36677322" display_stop="36784062" Strand="-" />
          </Location>
          <OMIM>160775</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_002473.6(MYH9):c.3195_3215dup (p.Gln1068_Leu1074dup)</Name>
      <CanonicalSPDI>NC_000022.11:36296899:GCGATCTGGGCCTGGAGCTCGGCGATCTGG:GCGATCTGGGCCTGGAGCTCGGCGATCTGGGCCTGGAGCTCGGCGATCTGG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>22q12.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="22" Accession="NC_000022.11" start="36296899" stop="36296900" display_start="36296899" display_stop="36296900" variantLength="21" positionVCF="36296899" referenceAlleleVCF="C" alternateAlleleVCF="CGCGATCTGGGCCTGGAGCTCG" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="22" Accession="NC_000022.10" start="36692945" stop="36692946" display_start="36692945" display_stop="36692946" variantLength="21" positionVCF="36692945" referenceAlleleVCF="C" alternateAlleleVCF="CGCGATCTGGGCCTGGAGCTCG" />
      </Location>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_567" sequenceAccession="LRG_567">
            <Expression>LRG_567:g.96099_96119dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_567t1" sequenceAccession="LRG_567t1">
            <Expression>LRG_567t1:c.3195_3215dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_567p1" sequenceAccession="LRG_567p1" change="p.Gln1068_Leu1074dup">
            <Expression>LRG_567p1:p.Gln1068_Leu1074dup</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000022.10" sequenceAccession="NC_000022" sequenceVersion="10" change="g.36692955_36692975dup" Assembly="GRCh37">
            <Expression>NC_000022.10:g.36692955_36692975dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000022.11" sequenceAccession="NC_000022" sequenceVersion="11" change="g.36296909_36296929dup" Assembly="GRCh38">
            <Expression>NC_000022.11:g.36296909_36296929dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011884.2" sequenceAccession="NG_011884" sequenceVersion="2" change="g.96099_96119dup">
            <Expression>NG_011884.2:g.96099_96119dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_002473.6" sequenceAccession="NM_002473" sequenceVersion="6" change="c.3195_3215dup" MANESelect="true">
            <Expression>NM_002473.6:c.3195_3215dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_002464.1" sequenceAccession="NP_002464" sequenceVersion="1" change="p.Gln1068_Leu1074dup">
            <Expression>NP_002464.1:p.Gln1068_Leu1074dup</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001821" Type="inframe_insertion" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA10575522" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="160775.0014" DB="OMIM" />
        <XRef Type="rs" ID="876661302" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff reviewed the sequence information reported in PubMed 19450438 Fig. 3B to determine the location of this allele on the current reference sequence.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_002473.6(MYH9):c.3195_3215dup (p.Gln1068_Leu1074dup) AND Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss" Accession="RCV000015141" Version="21">
        <ClassifiedConditionList TraitSetID="21112">
          <ClassifiedCondition DB="MedGen" ID="C5200934">Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2009-07-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2009-07-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2015-10-11" MostRecentSubmission="2015-10-11">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">12792306</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19450438</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="21112" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2734" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">BLEEDING DISORDER, PLATELET-TYPE, 6</ElementValue>
                <XRef Type="MIM" ID="155100" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MACROTHROMBOCYTOPENIA WITH LEUKOCYTE INCLUSIONS</ElementValue>
                <XRef Type="MIM" ID="155100" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">May-Hegglin anomaly</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">MACROTHROMBOCYTOPENIA WITH DISPERSED LEUKOCYTIC INCLUSIONS</ElementValue>
                <XRef Type="MIM" ID="605249" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MACROTHROMBOCYTOPENIA, NEPHRITIS, AND DEAFNESS</ElementValue>
                <XRef Type="MIM" ID="153650" DB="OMIM" />
                <XRef Type="MIM" ID="155100" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MACROTHROMBOCYTOPENIA, NEPHRITIS, DEAFNESS, AND LEUKOCYTE INCLUSIONS</ElementValue>
                <XRef Type="MIM" ID="155100" DB="OMIM" />
                <XRef Type="MIM" ID="153640" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">ALPORT SYNDROME WITH MACROTHROMBOCYTOPENIA</ElementValue>
                <XRef Type="MIM" ID="155100" DB="OMIM" />
                <XRef Type="MIM" ID="153640" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Macrothrombocytopenia and progressive sensorineural deafness</ElementValue>
                <XRef ID="Macrothrombocytopenia+progressive+deafness/4400" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss</ElementValue>
                <XRef ID="MONDO:0015912" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Sebastian syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Fechtner syndrome</ElementValue>
                <XRef ID="236422008" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Epstein syndrome</ElementValue>
                <XRef ID="MYH9+related+thrombocytopenia/5026" DB="Genetic Alliance" />
                <XRef ID="234485006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Sebastian platelet syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Giant platelet syndrome with thrombocytopenia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">DOHLE LEUKOCYTE INCLUSIONS WITH GIANT PLATELETS</ElementValue>
                <XRef Type="MIM" ID="155100" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">SBS</ElementValue>
                <XRef Type="MIM" ID="155100" DB="OMIM" />
                <XRef Type="MIM" ID="605249" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">EPSTNS</ElementValue>
                <XRef Type="MIM" ID="155100" DB="OMIM" />
                <XRef Type="MIM" ID="153650" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">FTNS</ElementValue>
                <XRef Type="MIM" ID="155100" DB="OMIM" />
                <XRef Type="MIM" ID="153640" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">APSM</ElementValue>
                <XRef Type="MIM" ID="155100" DB="OMIM" />
                <XRef Type="MIM" ID="153640" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">MYH9RD</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">BDPLT6</ElementValue>
                <XRef Type="MIM" ID="155100" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">MATINS</ElementValue>
                <XRef Type="MIM" ID="155100" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">MYH9-Related Disorders</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">MYH9-Related Disease (MYH9-RD)</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">MYH9 related thrombocytopenia</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">MYH9-related disease (MYH9-RD) is characterized in all affected individuals by hematologic features present from birth consisting of platelet macrocytosis (i.e., &gt;40% of platelets larger than 3.9 Âµm in diameter), thrombocytopenia (platelet count &lt;150 x 109/L), and aggregates of the MYH9 protein in the cytoplasm of neutrophil granulocytes. Most affected individuals develop one or more additional extrahematologic manifestations of the disease over their lifetime, including sensorineural hearing loss, renal disease (manifesting initially as glomerular nephropathy), presenile cataracts, and/or elevation of liver enzymes.</Attribute>
                <XRef ID="NBK2689" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301740</ID>
                <ID Source="BookShelf">NBK2689</ID>
              </Citation>
              <XRef ID="182050" DB="Orphanet" />
              <XRef ID="C5200934" DB="MedGen" />
              <XRef ID="MONDO:0015912" DB="MONDO" />
              <XRef Type="MIM" ID="155100" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="35398" SubmissionDate="2018-06-13" DateLastUpdated="2015-10-11" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="160775.0014_MACROTHROMBOCYTOPENIA AND GRANULOCYTE INCLUSIONS" title="MYH9, 21-BP DUP_MACROTHROMBOCYTOPENIA AND GRANULOCYTE INCLUSIONS" />
        <ClinVarAccession Accession="SCV000035398" DateUpdated="2015-10-11" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2009-07-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 3 affected members of a family with May-Hegglin anomaly (MATINS; 155100), De Rocco et al. (2009) identified a heterozygous 21-bp duplication in exon 24 of the MYH9 gene, resulting in an in-frame duplication of 7 amino acids (E1066-A1072) in the rod domain. All patients had congenital macrothrombocytopenia and Dohle-like inclusion bodies in neutrophils, consistent with May-Hegglin anomaly, and 1 patient also had congenital cataracts, which is part of the phenotypic spectrum of MYH9-related disorders. Seri et al. (2003) identified the reciprocal in-frame deletion in another patient (160775.0013). Detailed sequence analysis of this region revealed a 16-nucleotide repeat that was likely responsible for unequal crossing-over.</Attribute>
              <Citation>
                <ID Source="PubMed">19450438</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">12792306</ID>
              </Citation>
              <XRef DB="OMIM" ID="155100" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MYH9" />
          </GeneList>
          <Name>MYH9, 21-BP DUP</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">21-BP DUP</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="160775.0014" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">MACROTHROMBOCYTOPENIA AND GRANULOCYTE INCLUSIONS</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
  </ClassifiedRecord>
</VariationArchive>